This article is more than 5 years old. Information may no longer be current.

Bausch + Lomb receives 510(k) clearance for Crystalsert 2.6 injector

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Bausch + Lomb announced it received FDA 510(k) clearance for its Crystalsert 2.6 injector.

The injector is designed to assist IOL delivery through an incision as small as 2.6 mm and can be used for the entire diopter range of Crystalens AO and Trulign toric IOLs, according to a company release.

“The CI-26 injector includes several enhancements designed to assist IOL delivery through a smaller incision,” Chuck Hess, vice president and general manager, U.S. Surgical, Bausch + Lomb, said in the release. “Surgeons already know the benefits of our Crystalens accommodating and Trulign toric lenses, and we are happy to provide them with a smaller incision option to deliver these benefits to their patients.”

The injector features a smooth, oval tip shape to allow for easy wound entry and help prevent tissue snagging, according to the company.